Bleeding and acute coronary syndromes: defining, predicting, and managing risk and outcomes

Area of Science:

• Cardiology
• Internal Medicine
• Clinical Research

Background:

• Acute coronary syndromes (ACS) significantly impact US morbidity and mortality.
• Recent advancements in ACS care include combined antiplatelet/anticoagulant therapy and early invasive risk stratification.
• These strategies improve major adverse cardiovascular events but elevate bleeding risk.

Purpose of the Study:

• To review the prevalence of bleeding in ACS management.
• To identify risk factors associated with bleeding in ACS patients.
• To outline strategies for minimizing bleeding risk during ACS treatment.

Main Methods:

• Literature review of studies on ACS management and bleeding.
• Analysis of the association between bleeding and subsequent adverse outcomes.
• Synthesis of current evidence on bleeding risk reduction strategies.

Main Results:

• Bleeding is a significant complication in ACS management.
• An association exists between bleeding events and increased mortality/morbidity in ACS patients.
• Minimizing bleeding risk is a key priority in contemporary ACS care.

Conclusions:

• Effective ACS management requires balancing the benefits of aggressive treatment with the risks of bleeding.
• Further research and clinical strategies are needed to mitigate bleeding complications.
• Reducing bleeding is essential for improving long-term outcomes in patients with acute coronary syndromes.